Animal studies have demonstrated that BPC-157 can promote the repair of skin, muscle, bone, ligaments, and tendons
Email us at [email protected]
Early recognition and intervention remain crucial for managing this condition effectively and preventing serious complications such as malnutrition, dehydration, and unpredictable blood sugar fluctuations
[2] Research indicates that ALA may improve symptoms of diabetic neuropathy: for example, clinical trials and meta-analyses have shown that intravenous ALA (typically 600 mg per day for 3 weeks) may significantly reduce neuropathic pain, paresthesia, and numbness in diabetic patients
This reduction was driven by reductions in both bolus (6.2 U [14.1, 3.5]) and basal insulin (3.5 U [9.7, 0.3])
Martn-Galln P, et al